SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-048213
Filing Date
2021-12-14
Accepted
2021-12-14 19:03:39
Documents
1
Period of Report
2021-12-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6032
  Complete submission text file 0000899243-21-048213.txt   7525
Mailing Address C/O MEDICS 8125 N. HAYDEN RD SCOTTSDALE AZ 85258
Business Address
PRYGOCKI MARK A SR (Reporting) CIK: 0001257544 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39802 | Film No.: 211492418

Mailing Address 555 SKOKIE BOULEVARD, SUITE 340 NORTHBROOK IL 60062
Business Address 555 SKOKIE BOULEVARD, SUITE 340 NORTHBROOK IL 60062 (847) 562-4300
Clarus Therapeutics Holdings, Inc. (Issuer) CIK: 0001817944 (see all company filings)

IRS No.: 851231852 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)